Comparing the baseline patient and tumor characteristics of these three groups, we found that patients progressing due to a PSA rise harbored significantly or clinically meaningful higher rates of de novo mHSPC and high-volume mHSPC, as well as higher PSA nadirs in mHSPC and PSA levels at mCRPC progression, relative to both compared groups. Here, KLK3 is linked to neoplasm.